Hematopoietic repopulating ability of CD34+progenitor cells ex vivo expanded with different cytokine combinations

Artificial Cells, Nanomedicine and Biotechnology

Volumn 43, Issue 6, 2015, Pages 398-402

  Du, Zheng ^a   Jin, Huili ^a   Cai, Haibo ^a   Yang, Shi ^a   Tan, Wen Song ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CD34+cells; Cytokine combination; Hematopoietic repopulating ability; Multi lineage reconstitution; NOD SCID mice

Indexed keywords

CELLS; EXPANSION; MAMMALS; MEDICAL PROBLEMS; STEM CELLS;

CYTOKINES; EX VIVO EXPANSION; HEMATOPOIETIC REPOPULATING ABILITY; HEMATOPOIETIC STEM CELLS; MULTI-LINEAGE RECONSTITUTION; NOD/SCID MICE; NON-OBESE DIABETICS; PROGENITOR CELL;

CYTOLOGY;

INTERLEUKIN 3; INTERLEUKIN 6; CD34 ANTIGEN; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD34 SELECTION; CELL POPULATION; CONTROLLED STUDY; ENGRAFTMENT; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MOUSE; NONHUMAN; STEM CELL EXPANSION; UMBILICAL CORD BLOOD CELL; ANIMAL; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; FEMALE; FETUS BLOOD; GENE EXPRESSION; GENETICS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MORTALITY; NONOBESE DIABETIC MOUSE; PRIMARY CELL CULTURE; PROCEDURES; SCID MOUSE; SURVIVAL ANALYSIS; TRANSPLANTATION; WHOLE BODY RADIATION; XENOGRAFT;

ANIMALS; ANTIGENS, CD34; CELL PROLIFERATION; FEMALE; FETAL BLOOD; GENE EXPRESSION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-6; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; PRIMARY CELL CULTURE; STEM CELL FACTOR; SURVIVAL ANALYSIS; THROMBOPOIETIN; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY IRRADIATION;

EID: 84974691352     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.897630     Document Type: Article

References (29)

1. Broxmeyer HE, Gluckman E, Auerbach A, Douglas GW, Friedman H, Cooper S, et al. 1990. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning. 8: 76–91.
2. Bryder D, Jacobsen SE. 2000. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood. 96: 1748–1755.
3. Chute JP, Muramoto G, Fung J, Oxford C. 2004. Quantitative analysis demonstrates expansion of SCID-Repopulating cells and increased engraftment capacity in human cord blood following ex vivo culture with human brain endothelial cells. Stem Cells. 22: 202–215.
4. Cláudia LS, Pedro ZA, Francisco S, Joaquim MS. 2011. Ex-vivo expansion of hematopoietic stem cells from umbilical cord blood, 1st Portuguese Meeting in Bioengineering (ENBENG).
5. +cells after ex vivo expansion. Exp Hematol. 29: 1465–1473.
6. +cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res. 33: 107–114.
7. Higuchi A, Yang ST, Li PT, Tamai M, Tagawa Y, Chang Y, et al. 2010. Direct ex vivo expansion of hematopoietic stem cells from umbilical cord blood on membranes. J Membr Sci. 351: 104–111.
8. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M. 1987. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci. 84: 9035–9039.
9. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. 2003. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo–expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 101: 5061–5067.
10. Kishimoto S, Nakamura S, Hattori H, Oonuma F, Kanatani Y, Tanaka Y, et al. 2009. Cytokine-immobilized microparticle-coated plates for culturing hematopoietic progenitor cells. J Control Release. 133: 185–190.
11. Kiyoshi A, Takashi Y, Tadayuki S, Hiroko M, Hideyuki M, Masayuki O, et al. 2006. Direct evidence for ex vivo expansion of human hematopoietic stem cells. Blood. 107: 3371–3377.
12. Koen VB. 2011. Cord blood transplant: the glass is half full-can we do better? Leuk Lymphoma. 52: 554–555.
13. Kusadasi N, van Soest PL, Mayen AE, Koevoet JL, Ploemacher RE. 2000. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia. 14: 1944–1953.
14. +cord blood cells. Exp Hematol. 30: 1036–1043.
15. +hematopoietic stem and progenitor cells before and after culture. Biotechnol Lett. 28: 389–394.
16. Loretta G, Stefania B, Fiorella S, Monica G, Orit K, Giuliana C,et al. 2003. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol. 31: 261–270.
17. -cells with preserved ability to engraft SCID-hu bone. Blood. 91: 1206–1215.
18. McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E. 2002. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol. 30: 612–616.
19. Noort WA, Wilpshaar J, Hertogh CD, Rad M, Lurvink EG, van Luxemburg-Heijs SA, et al. 2001. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34+ cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant. 28: 163–171.
20. +cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO. J Transl Med. 5: 53.
21. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. 1996. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood. 87: 30–37.
22. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. 2001. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 97: 2962–2971.
23. Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E. 2000. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 342: 1846–1854.
24. Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaski H, Hisakawa H, et al. 2000. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 105: 1013–1021.
25. +cells derived from human fetal liver as compared to fetal bone marrow. Haematologica. 86: 1021–1028.
26. Xu MJ, Tsuji K, Ueda T, Mukouyama YS, Hara T, Yang FC, et al. 1998. Stimulation of mouse and human primitive hematopoiesis by murine embryonic Aorta-Gonad-Mesonephros–derived stromal cell lines. Blood. 92: 2032–2040.
27. +cells grown in static and stirred culture systems in NOD/ SCID mice. Biotechnol Lett. 30: 61–65.
28. +cells derived from short-term cultured cord blood mononuclear cells. Biotechnol Bioprocess Eng. 14: 429–435.
29. Yao CL, Chu IM, Hsieh TB, Hwang SM. 2004. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol. 32: 720–727